Johnson & Johnson plans Ebola vaccine testing

SHARE Johnson & Johnson plans Ebola vaccine testing

Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker said Wednesday that the vaccine being developed by its Janssen Pharmaceutical Companies protects against an Ebola strain that is “highly similar” to the virus that has triggered the current outbreak in West Africa. Johnson & Johnson also plans to test whether its vaccine protects against the version causing the outbreak, which has killed more than 4,500 people.

Read more at Newsfeed.

The Latest
About 5 a.m., a car was traveling south in the 7000 block of South Jeffery Boulevard when it ran over four males.
Victor Manuel-Reyes, 36, was arrested Friday after he was identified as the person who rode on a scooter and sexually assaulted women.
The announcement from his agent followed news that the lauded writer was removed from a ventilator Saturday and able to talk and joke.
The Chicago Botanic Garden, marking its 50th anniversary with outdoor art, strives to delight, preserve and teach.
The area’s top 10 pass catchers include a Notre Dame commit, the Public League’s top prospect and four Big Ten recruits.